ChangT.M.S.: Removal of endogenous and exogenous toxins by a microencapsulated absorbent.Can. J. Physiol. Pharmacol., 47: 1043, 1969.
2.
DavidsonW.D., IsacoffW.H., BlockJ.B.: Methotrexate «escape» using charcoal hemoperfusion: an alternative to citrovorum «rescue».ASAIO Abstracts6: 16, 1977.
DjerassiI., CiesielkaW., KimJ.S.: Removal of methotrexate by filtration-adsorption using charcoal filters or by hemodialysis.Cancer Treatment Rep., 61: 751, 1977.
5.
DumontC., RangnoR.: Argument against hemoperfusion in drug overdose.J.A.M.A., 242: 1611, 1979.
6.
HillJ.B., PalaiaF.L., McAdamsJ.L., PalmerP.J., SkinnerJ.T., MaretS.M.: The rationale for fixed-bed charcoal in hemoperfusion.Kidney Int., 10: S–328, 1976.
MartinA.M., GibbinsJ.K., KimmittJ., RennieF.: Hemodialysis and hemoperfusion in the treatment of uremic pericarditis.Dialysis and Transplantation, 8: 135, 1979.
10.
NolanJ.P., McDevittJ.J., GoldmannG.S.: Endotoxin binding by charger and uncharged resins.PSEBM., 149: 766, 1975.
11.
OtsuboO., KiharaK., SimadaY., YamaguciJ., TakahashiI., YamadaY., InouT.: Treatment of uremic peripheral neuritis by direct hemoperfusion with activated charcoal.Abstract Kidney Int.16: 235, 1979.
12.
RabinE.: Personal communication.
13.
YatzidisH.: A convient hemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications.Proc. Europ. Dial. Transpl. Assoc., 1: 83, 1964.
